Neurolymphomatosis (NL) is defined as the infiltration of the peripheral nervous system including cranial nerves, peripheral nerves, roots, and plexus by non-Hodgkin's lymphoma and nontumorous lymphocytes.
CASE
A 59-year-old female visited our clinic due to right abducens nerve palsy presenting with binocular horizontal diplopia. She denied a past medical history except for hypertension, and reported that the present symptom had started only 3 days previously. Left facial palsy occurred 17 days after the appearance of the first symptom, and brain magnetic resonance imaging (MRI) showed left facial neuritis (Fig. 1A) . She was treated with oral corticosteroids, which improved the facial palsy. A month after the facial palsy she experienced mild weakness of left shoulder elevation (Medical Research Council grade 4), paresthesia, and pain in the left upper extremity. Electrophysiology showed reduced amplitudes of the compound motor action potentials in the left axillary nerve (4.2 mV) and musculocutaneous nerve (1.0 mV) compared with the right arm (29.3 mV and 10.2 mV, respectively). Needle electromyography revealed denervation of the left lateral deltoid and biceps brachii muscles (Table 1) . These findings were compatible with left upper brachial plexopathy. Spine MRI also revealed left brachial plexus swelling and enhancement (Fig. 1B) . Repeated cerebrospinal fluid (CSF) examinations were performed under suspicion of malignancy, but malignant cells were not detected. Positron emission tomography with fluorodexoyglucose integrated with computed tomography (FDGPET-CT) showed mild-to-moderate uptake along the left brachial plexus with no other systemic lesions (Fig. 1C) .
She was transferred to another hospital for a further indepth workup, which did not include a tissue biopsy. No Annals of Clinical Neurophysiology Volume 20, Number 1, January 2018 evidence of malignancy was found, and her symptoms improved with high-dose steroid treatment. Right leg weakness occurred 3 months later, at which time spine MRI revealed diffuse long segmental enhancements in the right lumbosacral plexus and both lumbar and sacral nerve roots. Brain MRI revealed multifocal leptomeningeal enhancement on the brain surface, indicating leptomeningeal enhancement of systemic lymphoma or leptomeningeal metastasis (Fig. 1D) . FDG-PET showed diffuse hypermetabolism along the lumbosacral and brachial plexus (Fig. 1E, F) . CSF cytology suggested a hematolymphoid malignancy with many atypical cells. The biopsy samples obtained in the C7 root were confirmed as DLBCL (Fig. 2) .
DISCUSSION
NL is a rare clinical entity caused by nerve infiltration by hematological neoplastic cells, and is characterized clinically by painful polyneuropathy or polyradiculopathy, cranial neuropathy, painless polyneuropathy, and peripheral mononeuropathy. 6 NL is related to B-cell non-Hodgkin's lymphoma (90% of cases), especially DLBCL, and acute leukemia (10% of cases). 1, 7 Secondary NL occurs in approximately 0.2% of all patients with non-Hodgkin's lymphoma. 7 The diverse presenting symptoms vary with the involved sites. According to a previous report, the affected neural structures are peripheral nerves (60%), spinal nerve roots (48%), cranial nerves (46%), and plexus (40%), with multiple sites involved in 58% of cases. 1 NL can be challenging to diagnose because not only may it mimic many conditions, but also requires histopathological proof. In addition, primary lymphomatosis of the cranial nerves and PCNSL are difficult to differentiate. 8 Thus, a nerve biopsy is the gold standard for diagnosing NL, but it is generally not performed due to its invasiveness; instead, ra- Fig. 2 . Biopsy of the C7 root showed infiltration by predominantly small lymphocytes (hematoxylin-eosin stain, original magnification ×200) (A), and diffuse CD20-positive cells (immunohistochemical stain, original magnification ×200) (B).
A B

